Psychedelics PharmAla Biotech ships first batch of MDMA and psilocybin to be used as medicines in Australia This is the first shipment that will be used specifically under the country's Authorized Prescriber Scheme enacted in July Rowan DunneNovember 7, 2023
Psychedelics Vancouver police raid Medicinal Mushroom Dispensary locations, owner arrested Dana Larsen owns three shops in Vancouver that openly sell psychedelics like psilocybin mushrooms, DMT and peyote Rowan DunneNovember 3, 2023
Psychedelics Māori group receives first psilocybin cultivation license in NZ to treat substance use disorders The license was granted to Rua Bioscience, a medical cannabis company based in Tairāwhiti Gisborne Rowan DunneOctober 30, 2023
Psychedelics Afghanistan Veteran gets Health Canada approval for psilocybin treatment from Apex Labs Kelsi Sheren said that other treatment methods for her PTSD and depression were ineffective Rowan DunneSeptember 28, 2023
Psychedelics Billionaire Steve Cohen’s Point 72 hedge fund takes 8.1% stake in Cybin It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety Rowan DunneSeptember 19, 2023
Psychedelics AI shows potential for predicting psilocybin therapy outcomes: COMPASS study The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy Rowan DunneSeptember 8, 2023
Psychedelics Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010 Rowan DunneAugust 10, 2023
Psychedelics Cybin reaches end of psilocybin analogue clinical trial for depression CYB003 is a molecule developed by the company with rapid onset and a short duration Rowan DunneAugust 3, 2023
Psychedelics Optimi Health files U.S. patent for psilocybin extraction process The psychedelic drug developer says the new method increases potency while maintaining the mushroom's botanical qualities Rowan DunneAugust 1, 2023
News Optimi Health disputes allegations of failing $1.2M supply agreement The company announced the supply agreement last May Natalia Buendia CalvilloJuly 28, 2023